| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Non-Randomized Controlled Trials as Topic | 6 | 2017 | 220 | 3.31 | Why? |
| HIV Infections | 51 | 2021 | 11620 | 3.01 | Why? |
| Anti-HIV Agents | 17 | 2019 | 2209 | 2.81 | Why? |
| Community Health Workers | 8 | 2017 | 468 | 2.64 | Why? |
| Sex Workers | 8 | 2019 | 348 | 1.68 | Why? |
| Video Recording | 3 | 2021 | 786 | 1.59 | Why? |
| Motion Pictures | 2 | 2020 | 62 | 1.54 | Why? |
| Anti-Retroviral Agents | 7 | 2018 | 1099 | 1.42 | Why? |
| South Africa | 29 | 2019 | 3326 | 1.38 | Why? |
| Antiretroviral Therapy, Highly Active | 6 | 2018 | 952 | 1.34 | Why? |
| Rural Population | 20 | 2021 | 2408 | 1.13 | Why? |
| Health Education | 4 | 2021 | 1539 | 1.07 | Why? |
| Community Health Services | 5 | 2017 | 1000 | 0.96 | Why? |
| Public Sector | 4 | 2018 | 204 | 0.96 | Why? |
| National Health Programs | 4 | 2017 | 807 | 0.96 | Why? |
| Mass Screening | 13 | 2019 | 8005 | 0.84 | Why? |
| CD4 Lymphocyte Count | 10 | 2019 | 1517 | 0.84 | Why? |
| Causality | 3 | 2021 | 857 | 0.83 | Why? |
| Family Characteristics | 5 | 2019 | 2551 | 0.83 | Why? |
| Bottle Feeding | 1 | 2019 | 28 | 0.78 | Why? |
| Research | 5 | 2019 | 2115 | 0.74 | Why? |
| Counselors | 1 | 2018 | 37 | 0.74 | Why? |
| Health Services Research | 4 | 2018 | 756 | 0.70 | Why? |
| Economic Competition | 1 | 2017 | 35 | 0.69 | Why? |
| Refugee Camps | 1 | 2018 | 62 | 0.69 | Why? |
| Self Administration | 1 | 2017 | 125 | 0.68 | Why? |
| Injections | 1 | 2018 | 237 | 0.68 | Why? |
| Holidays | 1 | 2020 | 311 | 0.64 | Why? |
| Delayed-Action Preparations | 1 | 2018 | 291 | 0.63 | Why? |
| Serologic Tests | 7 | 2019 | 4359 | 0.62 | Why? |
| Treatment Adherence and Compliance | 1 | 2017 | 194 | 0.61 | Why? |
| Tanzania | 6 | 2018 | 294 | 0.61 | Why? |
| Health Communication | 3 | 2021 | 1120 | 0.59 | Why? |
| Research Design | 10 | 2021 | 5830 | 0.57 | Why? |
| Medication Therapy Management | 1 | 2018 | 312 | 0.57 | Why? |
| Health Knowledge, Attitudes, Practice | 8 | 2021 | 8811 | 0.54 | Why? |
| Health Care Costs | 6 | 2021 | 1007 | 0.53 | Why? |
| Government Programs | 2 | 2019 | 512 | 0.53 | Why? |
| Review Literature as Topic | 1 | 2017 | 387 | 0.52 | Why? |
| Program Evaluation | 6 | 2019 | 1929 | 0.51 | Why? |
| Sexual Behavior | 3 | 2019 | 1322 | 0.51 | Why? |
| Hand Disinfection | 2 | 2020 | 1671 | 0.50 | Why? |
| Emigration and Immigration | 1 | 2018 | 501 | 0.49 | Why? |
| Family Health | 1 | 2018 | 731 | 0.48 | Why? |
| Insurance, Health | 1 | 2017 | 634 | 0.45 | Why? |
| Noncommunicable Diseases | 2 | 2019 | 934 | 0.43 | Why? |
| Primary Health Care | 4 | 2018 | 4839 | 0.43 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.40 | Why? |
| Pre-Exposure Prophylaxis | 2 | 2018 | 1138 | 0.40 | Why? |
| Longitudinal Studies | 8 | 2021 | 9893 | 0.40 | Why? |
| Nursing Staff | 1 | 2017 | 542 | 0.39 | Why? |
| Food Supply | 1 | 2017 | 1027 | 0.38 | Why? |
| Depressive Disorder, Major | 1 | 2018 | 852 | 0.38 | Why? |
| Patient Education as Topic | 1 | 2019 | 1476 | 0.38 | Why? |
| Adult | 56 | 2021 | 244371 | 0.38 | Why? |
| Patient Isolation | 3 | 2021 | 3182 | 0.37 | Why? |
| Young Adult | 35 | 2021 | 93724 | 0.36 | Why? |
| Refugees | 1 | 2018 | 809 | 0.36 | Why? |
| Zambia | 6 | 2018 | 401 | 0.36 | Why? |
| Breast Feeding | 1 | 2019 | 1585 | 0.36 | Why? |
| Immunoenzyme Techniques | 1 | 2010 | 448 | 0.35 | Why? |
| Uganda | 4 | 2019 | 1057 | 0.35 | Why? |
| Humans | 99 | 2021 | 930598 | 0.33 | Why? |
| Public Policy | 1 | 2020 | 1894 | 0.33 | Why? |
| Home Care Services | 1 | 2018 | 1351 | 0.33 | Why? |
| Delayed Diagnosis | 1 | 2017 | 1529 | 0.33 | Why? |
| HIV Seropositivity | 3 | 2018 | 320 | 0.33 | Why? |
| Antihypertensive Agents | 1 | 2019 | 1962 | 0.32 | Why? |
| Communicable Diseases | 2 | 2021 | 2148 | 0.32 | Why? |
| Trust | 1 | 2017 | 1487 | 0.32 | Why? |
| Female | 61 | 2021 | 380317 | 0.31 | Why? |
| Cluster Analysis | 4 | 2018 | 3001 | 0.30 | Why? |
| Health Promotion | 1 | 2019 | 2020 | 0.29 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.29 | Why? |
| Hypertension | 4 | 2019 | 8895 | 0.29 | Why? |
| Adolescent | 27 | 2021 | 86841 | 0.28 | Why? |
| Tenofovir | 2 | 2018 | 449 | 0.27 | Why? |
| Postnatal Care | 2 | 2018 | 346 | 0.27 | Why? |
| Patient Acceptance of Health Care | 3 | 2018 | 5002 | 0.27 | Why? |
| Surveys and Questionnaires | 15 | 2021 | 43792 | 0.27 | Why? |
| Social Stigma | 3 | 2017 | 1049 | 0.27 | Why? |
| Endemic Diseases | 2 | 2017 | 480 | 0.26 | Why? |
| Male | 48 | 2021 | 367725 | 0.26 | Why? |
| Developing Countries | 5 | 2019 | 4283 | 0.25 | Why? |
| Delivery of Health Care | 3 | 2019 | 15909 | 0.25 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2017 | 5164 | 0.25 | Why? |
| HIV | 3 | 2018 | 1116 | 0.24 | Why? |
| Social Media | 2 | 2021 | 5798 | 0.24 | Why? |
| Job Satisfaction | 2 | 2017 | 647 | 0.23 | Why? |
| Capacity Building | 2 | 2018 | 683 | 0.23 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.23 | Why? |
| Health Expenditures | 3 | 2021 | 904 | 0.23 | Why? |
| Policy Making | 2 | 2020 | 829 | 0.22 | Why? |
| Health Services Accessibility | 6 | 2021 | 10697 | 0.22 | Why? |
| Middle Aged | 37 | 2021 | 270681 | 0.21 | Why? |
| History, 20th Century | 2 | 2017 | 1282 | 0.21 | Why? |
| Regression Analysis | 2 | 2019 | 2484 | 0.21 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.21 | Why? |
| Africa South of the Sahara | 4 | 2017 | 1335 | 0.20 | Why? |
| Models, Theoretical | 4 | 2021 | 6659 | 0.20 | Why? |
| Secondary Care | 1 | 2020 | 160 | 0.20 | Why? |
| Patient Compliance | 2 | 2021 | 1468 | 0.20 | Why? |
| Residence Characteristics | 3 | 2018 | 1927 | 0.18 | Why? |
| Facility Design and Construction | 1 | 2020 | 189 | 0.18 | Why? |
| Cost of Illness | 3 | 2018 | 1903 | 0.18 | Why? |
| Continuity of Patient Care | 2 | 2018 | 1574 | 0.18 | Why? |
| Child Development | 2 | 2019 | 352 | 0.18 | Why? |
| Syria | 1 | 2018 | 170 | 0.18 | Why? |
| Disease Transmission, Infectious | 2 | 2018 | 9044 | 0.18 | Why? |
| Pregnancy, Unplanned | 1 | 2017 | 36 | 0.17 | Why? |
| Fees and Charges | 1 | 2017 | 27 | 0.17 | Why? |
| Marital Status | 1 | 2018 | 186 | 0.17 | Why? |
| Benzoxazines | 1 | 2017 | 103 | 0.17 | Why? |
| Social Conditions | 1 | 2020 | 196 | 0.17 | Why? |
| Global Health | 7 | 2021 | 13911 | 0.17 | Why? |
| Time and Motion Studies | 1 | 2017 | 65 | 0.17 | Why? |
| Prenatal Care | 2 | 2018 | 1314 | 0.17 | Why? |
| Health Policy | 4 | 2018 | 6242 | 0.17 | Why? |
| Contraception Behavior | 1 | 2017 | 60 | 0.17 | Why? |
| Poisson Distribution | 1 | 2018 | 348 | 0.16 | Why? |
| Incidence | 10 | 2019 | 25622 | 0.16 | Why? |
| Emtricitabine | 1 | 2017 | 202 | 0.16 | Why? |
| History, 18th Century | 1 | 2017 | 192 | 0.16 | Why? |
| Mortality, Premature | 1 | 2018 | 111 | 0.16 | Why? |
| Population Surveillance | 5 | 2021 | 4967 | 0.16 | Why? |
| Personnel Turnover | 1 | 2017 | 121 | 0.16 | Why? |
| Focus Groups | 2 | 2017 | 811 | 0.16 | Why? |
| Censuses | 1 | 2017 | 172 | 0.16 | Why? |
| Tertiary Healthcare | 1 | 2020 | 616 | 0.16 | Why? |
| Eligibility Determination | 1 | 2018 | 255 | 0.16 | Why? |
| Measles Vaccine | 1 | 2019 | 301 | 0.15 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2018 | 260 | 0.15 | Why? |
| Multicenter Studies as Topic | 2 | 2020 | 2437 | 0.15 | Why? |
| Health | 1 | 2017 | 130 | 0.15 | Why? |
| Costs and Cost Analysis | 2 | 2018 | 694 | 0.15 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2021 | 10649 | 0.15 | Why? |
| Blood Pressure Determination | 1 | 2019 | 450 | 0.15 | Why? |
| Health Surveys | 4 | 2019 | 2841 | 0.15 | Why? |
| History, 19th Century | 1 | 2017 | 384 | 0.15 | Why? |
| Hospitals, Special | 1 | 2020 | 523 | 0.14 | Why? |
| Diabetes Mellitus | 4 | 2018 | 8207 | 0.14 | Why? |
| Mammography | 1 | 2019 | 410 | 0.14 | Why? |
| European Union | 1 | 2019 | 565 | 0.14 | Why? |
| Epidemiologic Research Design | 1 | 2017 | 166 | 0.14 | Why? |
| Ethics, Research | 1 | 2018 | 328 | 0.14 | Why? |
| Intention | 2 | 2021 | 1380 | 0.14 | Why? |
| Population Dynamics | 1 | 2018 | 378 | 0.14 | Why? |
| Epidemiologic Methods | 1 | 2018 | 392 | 0.14 | Why? |
| Diffusion of Innovation | 1 | 2018 | 440 | 0.14 | Why? |
| Hospitals, Public | 1 | 2020 | 774 | 0.14 | Why? |
| Infant | 9 | 2020 | 30274 | 0.13 | Why? |
| Urban Population | 3 | 2021 | 2000 | 0.13 | Why? |
| Goals | 1 | 2017 | 335 | 0.13 | Why? |
| Meta-Analysis as Topic | 1 | 2021 | 1289 | 0.13 | Why? |
| Early Medical Intervention | 1 | 2017 | 487 | 0.13 | Why? |
| Depression | 1 | 2018 | 14116 | 0.13 | Why? |
| Feasibility Studies | 3 | 2018 | 3467 | 0.13 | Why? |
| Epidemics | 3 | 2019 | 6407 | 0.13 | Why? |
| Cost-Benefit Analysis | 3 | 2021 | 2259 | 0.13 | Why? |
| Sexism | 1 | 2017 | 278 | 0.13 | Why? |
| Blood Pressure | 3 | 2019 | 2198 | 0.13 | Why? |
| Prevalence | 10 | 2021 | 25773 | 0.13 | Why? |
| Weight Gain | 1 | 2018 | 552 | 0.13 | Why? |
| Drug Utilization | 1 | 2018 | 619 | 0.12 | Why? |
| Mobile Health Units | 1 | 2020 | 741 | 0.12 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.12 | Why? |
| Viral Load | 6 | 2018 | 15850 | 0.12 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.12 | Why? |
| Disclosure | 1 | 2017 | 423 | 0.12 | Why? |
| Government Regulation | 1 | 2020 | 842 | 0.12 | Why? |
| Infant, Newborn | 6 | 2020 | 23105 | 0.12 | Why? |
| Spatial Analysis | 1 | 2018 | 878 | 0.12 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.12 | Why? |
| Disease Eradication | 1 | 2018 | 581 | 0.12 | Why? |
| Sexual Partners | 1 | 2017 | 612 | 0.12 | Why? |
| Cross-Sectional Studies | 9 | 2021 | 53120 | 0.12 | Why? |
| HIV-1 | 2 | 2017 | 3365 | 0.12 | Why? |
| Confidentiality | 1 | 2017 | 581 | 0.12 | Why? |
| Medication Adherence | 2 | 2018 | 1270 | 0.11 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.11 | Why? |
| Consumer Health Information | 1 | 2020 | 750 | 0.11 | Why? |
| Measles | 1 | 2019 | 608 | 0.11 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.11 | Why? |
| Greece | 1 | 2018 | 2091 | 0.11 | Why? |
| Overweight | 1 | 2018 | 916 | 0.11 | Why? |
| Germany | 4 | 2021 | 9196 | 0.11 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.11 | Why? |
| Mothers | 2 | 2019 | 1624 | 0.11 | Why? |
| Health Care Reform | 1 | 2017 | 409 | 0.11 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.11 | Why? |
| Nutritional Status | 2 | 2019 | 1403 | 0.11 | Why? |
| General Practitioners | 1 | 2018 | 568 | 0.11 | Why? |
| Attitude of Health Personnel | 3 | 2017 | 4741 | 0.11 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 533 | 0.11 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.11 | Why? |
| Abortion, Induced | 1 | 2017 | 437 | 0.11 | Why? |
| Pregnancy | 5 | 2019 | 23879 | 0.11 | Why? |
| Viremia | 1 | 2018 | 1020 | 0.11 | Why? |
| Child Health Services | 1 | 2017 | 520 | 0.11 | Why? |
| Quality-Adjusted Life Years | 3 | 2018 | 511 | 0.10 | Why? |
| Cohort Studies | 7 | 2018 | 36005 | 0.10 | Why? |
| Public Health | 4 | 2021 | 16359 | 0.10 | Why? |
| Early Diagnosis | 1 | 2019 | 2443 | 0.10 | Why? |
| Commerce | 1 | 2020 | 1109 | 0.10 | Why? |
| Child | 9 | 2021 | 70012 | 0.10 | Why? |
| Aged, 80 and over | 10 | 2020 | 88759 | 0.10 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.10 | Why? |
| Health Facilities | 1 | 2018 | 1230 | 0.10 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.10 | Why? |
| Calibration | 1 | 2010 | 307 | 0.10 | Why? |
| Child, Preschool | 9 | 2020 | 36283 | 0.10 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.10 | Why? |
| Aged | 16 | 2020 | 215776 | 0.10 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.09 | Why? |
| Europe | 3 | 2020 | 12702 | 0.09 | Why? |
| Time Factors | 5 | 2020 | 31397 | 0.09 | Why? |
| Risk Factors | 10 | 2020 | 71621 | 0.09 | Why? |
| Hyperglycemia | 1 | 2019 | 1363 | 0.09 | Why? |
| Maternal Health Services | 1 | 2017 | 808 | 0.09 | Why? |
| Quality Improvement | 2 | 2018 | 2435 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.09 | Why? |
| Confidence Intervals | 1 | 2010 | 744 | 0.09 | Why? |
| Statistics as Topic | 1 | 2010 | 370 | 0.09 | Why? |
| Burkina Faso | 2 | 2018 | 302 | 0.09 | Why? |
| Biomedical Research | 2 | 2018 | 5270 | 0.08 | Why? |
| Treatment Outcome | 6 | 2019 | 51732 | 0.08 | Why? |
| United States | 5 | 2021 | 46150 | 0.08 | Why? |
| China | 5 | 2021 | 50654 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2019 | 1956 | 0.08 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.08 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.08 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.08 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.08 | Why? |
| Sex Factors | 3 | 2018 | 11014 | 0.08 | Why? |
| Logistic Models | 2 | 2019 | 9089 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.08 | Why? |
| Monte Carlo Method | 2 | 2020 | 577 | 0.08 | Why? |
| Transients and Migrants | 1 | 2018 | 1468 | 0.08 | Why? |
| Tuberculosis | 2 | 2018 | 2895 | 0.07 | Why? |
| Diet | 1 | 2018 | 2052 | 0.07 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.07 | Why? |
| Health Resources | 1 | 2018 | 2592 | 0.07 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.07 | Why? |
| Blood Glucose | 1 | 2019 | 3642 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.07 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.07 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.07 | Why? |
| Travel | 2 | 2021 | 7220 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.07 | Why? |
| Cardiovascular Diseases | 3 | 2018 | 11497 | 0.07 | Why? |
| World Health Organization | 1 | 2017 | 4213 | 0.07 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.06 | Why? |
| Family | 1 | 2017 | 2909 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Socioeconomic Factors | 2 | 2017 | 8495 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.06 | Why? |
| Information Storage and Retrieval | 1 | 2007 | 644 | 0.06 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.06 | Why? |
| Nurses | 1 | 2017 | 2285 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.05 | Why? |
| Rural Health Services | 2 | 2018 | 496 | 0.05 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2019 | 3633 | 0.05 | Why? |
| Healthcare Disparities | 1 | 2018 | 3893 | 0.05 | Why? |
| Africa | 2 | 2021 | 2986 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Least-Squares Analysis | 1 | 2021 | 254 | 0.05 | Why? |
| Cost Control | 1 | 2020 | 35 | 0.05 | Why? |
| Demography | 1 | 2007 | 1660 | 0.05 | Why? |
| Urbanization | 1 | 2021 | 133 | 0.05 | Why? |
| Wasting Syndrome | 1 | 2019 | 42 | 0.05 | Why? |
| Botswana | 1 | 2019 | 98 | 0.05 | Why? |
| Thinness | 1 | 2019 | 99 | 0.05 | Why? |
| Growth Disorders | 1 | 2019 | 91 | 0.05 | Why? |
| Lesotho | 1 | 2017 | 11 | 0.05 | Why? |
| Data Collection | 2 | 2018 | 1769 | 0.05 | Why? |
| Job Description | 1 | 2017 | 20 | 0.05 | Why? |
| Alkynes | 1 | 2017 | 98 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 3 | 2018 | 11559 | 0.04 | Why? |
| Siblings | 1 | 2019 | 226 | 0.04 | Why? |
| Jamaica | 1 | 2017 | 47 | 0.04 | Why? |
| Body Height | 1 | 2018 | 100 | 0.04 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.04 | Why? |
| Self-Control | 1 | 2018 | 73 | 0.04 | Why? |
| Age Distribution | 2 | 2018 | 3567 | 0.04 | Why? |
| Normal Distribution | 1 | 2017 | 64 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2019 | 673 | 0.04 | Why? |
| Mozambique | 1 | 2017 | 205 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Single-Blind Method | 1 | 2021 | 1283 | 0.04 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Financing, Government | 1 | 2021 | 434 | 0.04 | Why? |
| Systole | 1 | 2017 | 252 | 0.04 | Why? |
| Rural Health | 1 | 2018 | 243 | 0.04 | Why? |
| Condoms | 1 | 2017 | 235 | 0.04 | Why? |
| Clinical Protocols | 2 | 2017 | 2734 | 0.04 | Why? |
| Salaries and Fringe Benefits | 1 | 2017 | 182 | 0.04 | Why? |
| Medical Audit | 1 | 2017 | 218 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2018 | 345 | 0.04 | Why? |
| Interrupted Time Series Analysis | 1 | 2019 | 868 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Qualitative Research | 2 | 2018 | 4337 | 0.04 | Why? |
| Cyclopropanes | 1 | 2017 | 332 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.04 | Why? |
| Bangladesh | 1 | 2020 | 1620 | 0.03 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.03 | Why? |
| Fasting | 1 | 2019 | 555 | 0.03 | Why? |
| Cause of Death | 2 | 2019 | 4823 | 0.03 | Why? |
| Contraception | 1 | 2017 | 291 | 0.03 | Why? |
| Mentors | 1 | 2017 | 372 | 0.03 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.03 | Why? |
| Cell Phone | 1 | 2021 | 750 | 0.03 | Why? |
| Counseling | 1 | 2019 | 747 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.03 | Why? |
| Switzerland | 1 | 2020 | 2738 | 0.03 | Why? |
| Geography | 1 | 2017 | 1801 | 0.03 | Why? |
| Netherlands | 1 | 2020 | 3533 | 0.03 | Why? |
| Temperature | 1 | 2021 | 2305 | 0.03 | Why? |
| India | 2 | 2019 | 11875 | 0.03 | Why? |
| Opportunistic Infections | 1 | 2017 | 602 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Health Status Disparities | 2 | 2018 | 4072 | 0.03 | Why? |
| Algorithms | 2 | 2017 | 7346 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2017 | 781 | 0.03 | Why? |
| Malnutrition | 1 | 2019 | 932 | 0.02 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.02 | Why? |
| Sex Characteristics | 1 | 2017 | 1120 | 0.02 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Sensitivity and Specificity | 1 | 2010 | 22971 | 0.02 | Why? |
| Attitude | 1 | 2018 | 1481 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Intracranial Hemorrhages | 1 | 2017 | 1170 | 0.02 | Why? |
| Research Personnel | 1 | 2018 | 1037 | 0.02 | Why? |
| Republic of Korea | 1 | 2020 | 5858 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Disabled Persons | 1 | 2018 | 1152 | 0.02 | Why? |
| Workload | 1 | 2017 | 1887 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Body Mass Index | 1 | 2019 | 4306 | 0.02 | Why? |
| Employment | 1 | 2017 | 1754 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Uncertainty | 1 | 2017 | 1888 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2017 | 2517 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2019 | 3419 | 0.02 | Why? |
| Computer Simulation | 1 | 2019 | 4982 | 0.02 | Why? |
| France | 1 | 2020 | 12074 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.02 | Why? |
| Risk Assessment | 2 | 2017 | 25439 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.01 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.01 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2017 | 15978 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |